Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
JCO Global Oncology|August 1, 2024
<i>JCO Global Oncology</i> Editorial on Resource-Stratified GuidelinesTemidayo Fadelu, Zeba Aziz, Sarah Temin, et al.
Lancet (London, England)|November 29, 2019
Quantifying the benefit of non-small-cell lung cancer immunotherapy - Authors' replyTony S K Mok, Jin Zhang, Gilberto Lopes
JCO Global Oncology|February 13, 2023
Advancing Global Oncology Readership Needs: Pushing Forward Since 2015Melinda Mushonga, Hongcheng Zhu, Mary Gospodarowicz, et al.
Cureus|November 4, 2020
Unusual Presentation of Renal Medullary Carcinoma With Undiagnosed Sickle Cell TraitFahmin Basher, Giselle Dutcher, Jonathan S England, et al.
Chinese Clinical Oncology|September 2, 2025
Evolving strategies in the management of non-small cell lung cancer brain metastases: insights from the C-Brain trialChinmay T Jani, Gilberto Lopes, Zhonglin Hao, et al.
Journal of Global Oncology|July 19, 2017
Increasing Access to Oral Anticancer Medicines in Middle-Income Countries: A Case Study of Private Health Insurance Coverage in BrazilElize Massard da Fonseca, Francisco Inácio Bastos, Gilberto Lopes
Breast Cancer Research and Treatment|December 28, 2011
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancerAlberto J Montero, Kiran Avancha, Stefan Glück, et al.
Breast Cancer Research and Treatment|November 13, 2012
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancerGilberto Lopes, Stefan Glück, Kiran Avancha, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participantsPui San Tan, Pedro Aguiar, Benjamin Haaland, et al.
Journal of Global Oncology|July 19, 2017
Surgery for CNS Tumors in the Brazilian National Health Care SystemLuciola Pontes, Maryam Nemati Shafaee, Benjamin Haaland, et al.
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
JCO Global Oncology|August 1, 2024
<i>JCO Global Oncology</i> Editorial on Resource-Stratified GuidelinesTemidayo Fadelu, Zeba Aziz, Sarah Temin, et al.
Lancet (London, England)|November 29, 2019
Quantifying the benefit of non-small-cell lung cancer immunotherapy - Authors' replyTony S K Mok, Jin Zhang, Gilberto Lopes
JCO Global Oncology|February 13, 2023
Advancing Global Oncology Readership Needs: Pushing Forward Since 2015Melinda Mushonga, Hongcheng Zhu, Mary Gospodarowicz, et al.
Cureus|November 4, 2020
Unusual Presentation of Renal Medullary Carcinoma With Undiagnosed Sickle Cell TraitFahmin Basher, Giselle Dutcher, Jonathan S England, et al.
Chinese Clinical Oncology|September 2, 2025
Evolving strategies in the management of non-small cell lung cancer brain metastases: insights from the C-Brain trialChinmay T Jani, Gilberto Lopes, Zhonglin Hao, et al.
Journal of Global Oncology|July 19, 2017
Increasing Access to Oral Anticancer Medicines in Middle-Income Countries: A Case Study of Private Health Insurance Coverage in BrazilElize Massard da Fonseca, Francisco Inácio Bastos, Gilberto Lopes
Breast Cancer Research and Treatment|December 28, 2011
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancerAlberto J Montero, Kiran Avancha, Stefan Glück, et al.
Breast Cancer Research and Treatment|November 13, 2012
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancerGilberto Lopes, Stefan Glück, Kiran Avancha, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participantsPui San Tan, Pedro Aguiar, Benjamin Haaland, et al.
Journal of Global Oncology|July 19, 2017
Surgery for CNS Tumors in the Brazilian National Health Care SystemLuciola Pontes, Maryam Nemati Shafaee, Benjamin Haaland, et al.
Pageof 18